Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

46.10p
   
  • Change Today:
      0.25p
  • 52 Week High: 49.55
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 324,847
  • Market Cap: £249.20m
  • RiskGrade: 119
  • Beta: 0.92

Dividend Data

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Total Dividendn/a1.78p1.69p1.61p0.54p
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 180.68 167.42 163.21 129.80 135.64
Operating Profit/(Loss) (38.44) (17.69) 21.58 16.32 35.63
Net Interest (10.36) (5.36) (3.42) (3.30) (4.55)
Profit Before Tax (48.80) (23.05) 18.16 13.02 31.08
Profit After Tax (33.14) (21.21) 7.32 8.03 25.01
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD (33.14) (21.21) 7.32 8.03 25.01
Attributable to:          
Equity Holders of Parent Company (33.14) (21.21) 7.32 8.03 25.01
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic (6.13p) (3.93p) 1.37p 1.51p 4.80p
Earnings per Share - Diluted (6.13p) (3.93p) 1.35p 1.49p 4.72p
Earnings per Share - Adjusted 4.55p 4.28p 6.39p 5.11p 5.09p
Continuing and Discontinued EPS          
Earnings per Share - Basic (6.13p) (3.93p) 1.37p 1.51p 4.80p
Earnings per Share - Diluted (6.13p) (3.93p) 1.35p 1.49p 4.72p
Earnings per Share - Adjusted 4.55p 4.28p 6.39p 5.11p 5.09p
           
Dividend per Share n/a 1.78p 1.69p 1.61p 0.54p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 5.72 5.58 4.83 15.92 11.55
Intangible Assets 299.98 393.37 413.74 412.87 328.66
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a n/a n/a n/a
Other Financial Assets 0.08 0.02 n/a n/a n/a
Other Non-Current Assets 5.05 4.70 3.90 2.82 2.39
  310.83 403.67 422.47 431.61 342.60
Current Assets          
Inventories 25.71 24.29 21.08 22.92 15.52
Trade & Other Receivables 54.72 49.32 30.82 25.11 30.99
Cash at Bank & in Hand 22.44 31.71 29.06 28.90 17.83
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 1.23 0.16 0.06 0.31 0.70
  104.10 105.48 81.02 77.24 65.04
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 414.92 509.15 503.49 508.85 407.64
           
Liabilities          
Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Other Current Liabilities 40.57 47.02 40.58 30.19 24.21
  40.57 47.02 40.58 30.19 24.21
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 113.65 133.74 116.06 138.33 77.04
Provisions 37.86 59.46 61.73 56.18 29.81
Other Non-Current Liabilities 4.97 3.41 2.64 3.20 2.40
  156.48 196.61 180.42 197.71 109.25
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 197.05 243.64 221.00 227.90 133.46
           
Net Assets 217.87 265.52 282.49 280.96 274.18
           
Capital & Reserves          
Share Capital 5.40 5.40 5.38 5.33 5.29
Share Premium Account 151.68 151.65 151.33 150.65 149.04
Other Reserves 17.42 22.37 9.36 7.28 7.34
Retained Earnings 43.37 86.09 116.42 117.70 112.51
Shareholders Funds 217.87 265.52 282.49 280.96 274.18
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 217.87 265.52 282.49 280.96 274.18
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities 31.41 20.97 38.66 41.57 35.76
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (0.92) (17.02) (4.60) (85.86) (3.28)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (39.19) (0.88) (34.34) 55.75 (25.20)
Net Increase/Decrease In Cash (8.70) 3.07 (0.28) 11.45 7.28
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted 8.9 12.4 17.0 17.1 16.5
PEG - Adjusted 1.5 n/a 0.7 n/a 1.4
Earnings per Share Growth - Adjusted 6% -33% 25% 0% 12%
Dividend Cover n/a 2.41 3.78 3.17 9.50
Revenue per Share 33.42p 30.97p 0.30p 24.01p 25.09p
Pre-Tax Profit per Share (9.03p) (4.26p) 0.034p 2.41p 5.75p
Operating Margin (21.28%) (10.57%) 13.22% 12.57% 26.27%
Return on Capital Employed n/a n/a 0.47% 26.07% 68.03%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 8.9 12.4 1,686.8 17.1 16.5
PEG - Adjusted 1.5 0.0 n/a n/a 1.4
Earnings per Share Growth - Adjusted 6% 6,536% -99% 0% 12%
Dividend Cover n/a 2.41 0.04 3.17 9.50
           
Dividend Yield 0.0% 3.4% 1.6% 1.8% 0.6%
Dividend per Share Growth n/a 5.03% 5.03% 200.37% (63.39%)
Operating Cash Flow per Share 5.81p 3.88p 7.15p 7.69p 6.62p
Cash Incr/Decr per Share (1.61p) 0.57p n/a 2.12p 1.35p
Net Asset Value per Share (exc. Intangibles) (15.19p) (23.65p) (24.28p) (24.40p) (10.08p)
Net Gearing 41.86% 38.43% 30.80% 38.95% 21.60%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page